HUNILIFE BIOTECHNOLOGY, INC.
🇹🇼Taiwan
- Country
- 🇹🇼Taiwan
- Ownership
- Private
- Established
- 2012-11-21
- Employees
- 11
- Market Cap
- -
- Website
- http://www.hunilife.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 1
1 (50.0%)Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients
Not Applicable
- Conditions
- Multiple Myeloma Refractory
- Interventions
- First Posted Date
- 2025-10-07
- Last Posted Date
- 2025-10-07
- Lead Sponsor
- HuniLife Biotechnology, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT07210047
- Locations
- 🇨🇳
Far Eastern Memorial Hospital, Taipei, Taiwan
A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001
- First Posted Date
- 2020-09-07
- Last Posted Date
- 2025-09-24
- Lead Sponsor
- HuniLife Biotechnology, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT04540770
- Locations
- 🇨🇳
Mackay Memorial Hospital, New Taipei City, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
News
No news found